[Form 4] Nukkleus Inc. Insider Trading Activity

Rhea-AI Filing Summary

Nukkleus Inc. (NUKK) reported an insider equity award on Form 4. A company director received 5,000 shares of common stock on 11/13/2025. The shares, with a stated price of $0 per share, were issued under the company’s 2025 Equity Incentive Plan as consideration for services rendered to Nukkleus Inc.

Following this grant, the reporting person beneficially owns 15,000 shares of Nukkleus common stock in direct ownership. The filing is made by a single reporting person in their capacity as a director of the company.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nagar Tomer

(Last) (First) (Middle)

C/O NUKKLEUS INC.

575 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Nukkleus Inc. [ NUKK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value per share	11/13/2025		A		5,000	A	$0(1)	15,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.

	/s/ Tomer Nagar	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Nukkleus Inc. (NUKK) report on this Form 4?

Nukkleus Inc. reported that a director received 5,000 shares of its common stock on 11/13/2025 as an equity award.

How many Nukkleus (NUKK) shares does the reporting person own after this transaction?

After the reported transaction, the director beneficially owns 15,000 shares of Nukkleus Inc. common stock in direct ownership.

At what price were the Nukkleus (NUKK) shares granted on this Form 4?

The 5,000 shares of Nukkleus common stock were reported with a price of $0 per share, reflecting a stock grant rather than an open-market purchase.

Under which plan were the Nukkleus (NUKK) shares issued to the director?

The shares were issued under Nukkleus Inc.’s 2025 Equity Incentive Plan in consideration of services rendered to the company.

What is the relationship of the reporting person to Nukkleus Inc. (NUKK)?

The reporting person is a director of Nukkleus Inc., as indicated in the relationship section of the Form 4.

Is this Nukkleus (NUKK) Form 4 filed by more than one reporting person?

No. The Form 4 indicates it is filed by one reporting person, not by a group.

Why were the 5,000 Nukkleus (NUKK) shares issued to the director?

The filing explains that the shares were issued in consideration of services rendered to Nukkleus Inc. under the 2025 Equity Incentive Plan.